RXRX Recursion Pharmaceuticals, Inc.

RXRX (Recursion Pharmaceuticals, Inc.) is a US stock trading at $3.18, +0.32% on the day. mdvin's smart-money engine places it in the EXITED operator phase, with a GRINDER accumulation style. Current conviction is 49/100 and the Buy Score is 45. The active signal is QUIET. It has ignited 5 time(s) in the last 90 sessions, paying off 48% of the time (typical run +6.8%). Reversal/trap risk is graded MEDIUM. On fundamentals it looks unprofitable (quality grade F, analyst upside +128.00%).